SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Iverson Genetic Diagnostics Release: WARFARIN Study Launched at Wellstar International, Inc. Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin